 |
|
|
|
|
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2022 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
MimiVax LLC
| MimiVax LLC
Elm & Carlton Streets MRC 105,
Buffalo, NY 14263 | |
| | | | Phone: | (716) 845-8850 | | Year Established: | 2011 | | Main Contact: | Anil Goyal , Ph.D., VP, Business Development & Strategy | | | | Other Contacts: | Michael Ciesielski, Ph.D., CSO
Robert Fenstermaker, MD, CMO
| | | | Company Description | | MimiVax is a clinical-stage biotechnology company focused on the development and commercialization of immunotherapeutic vaccines and targeted therapies for cancer treatment. Its lead candidate, SurVaxM, an immunotherapy developed at Roswell Park Cancer Institute, is currently undergoing Phase 1 study in multiple myeloma and Phase 2 study in glioblastoma. | |
|
|
|
|
|
|
|
